Morinidazole is an organic molecular entity being investigated as a pharmaceutical active ingredient. It has been studied in clinical trials for conditions such as appendicitis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 92478-27-8
(E)-3-(6-(1-Hydroxy-3-(pyrrolidin-1-yl)-1-(p-tolyl)propyl)pyridin-2-yl)acrylic acid
pharmaceutical raw material
Deschloro Lapatinib
pharmaceutical raw material
Pyridoxine
pharmaceutical raw material
Alpha-Aescin
pharmaceutical raw material
(2S,3R,11bR)-9,10-Dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-ol
pharmaceutical raw material
Zidovudine triphosphate
pharmaceutical raw material
(EZ)-cefprozil
pharmaceutical raw material
(E)-cefprozil
pharmaceutical raw material
1-(2-methyl-5-nitroimidazol-1-yl)-3-morpholin-4-ylpropan-2-ol
GAZGHCHCYRSPIV-UHFFFAOYSA-N
CC1=NC=C(N1CC(CN2CCOCC2)O)[N+](=O)[O-]